Shao, H., Chung, J., Balaj, L., Charest, A., Bigner, D. D., Carter, B. S., … Lee, H. (2012). 443 Protein Typing of Circulating Microvesicles Allows Real-time Monitoring of Glioblastoma Therapy. In European Journal of Cancer (Vol. 48, pp. 137–138). Elsevier BV. https://doi.org/10.1016/s0959-8049(12)72241-4

Shao, H., J. Chung, L. Balaj, A. Charest, D. D. Bigner, B. S. Carter, F. H. Hochberg, X. O. Breakefield, R. Weissleder, and H. Lee. “443 Protein Typing of Circulating Microvesicles Allows Real-time Monitoring of Glioblastoma Therapy.” In European Journal of Cancer, 48:137–38. Elsevier BV, 2012. https://doi.org/10.1016/s0959-8049(12)72241-4.

Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, et al. 443 Protein Typing of Circulating Microvesicles Allows Real-time Monitoring of Glioblastoma Therapy. In: European Journal of Cancer. Elsevier BV; 2012. p. 137–8.

Shao, H., et al. “443 Protein Typing of Circulating Microvesicles Allows Real-time Monitoring of Glioblastoma Therapy.” European Journal of Cancer, vol. 48, Elsevier BV, 2012, pp. 137–38. Crossref, doi:10.1016/s0959-8049(12)72241-4.

Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS, Hochberg FH, Breakefield XO, Weissleder R, Lee H. 443 Protein Typing of Circulating Microvesicles Allows Real-time Monitoring of Glioblastoma Therapy. European Journal of Cancer. Elsevier BV; 2012. p. 137–138.